Showing 2,301 - 2,320 results of 2,530 for search '"Vaccine"', query time: 0.07s Refine Results
  1. 2301

    COVID-19 and the Medical Devices in India: Trade for a Resilient Health System by Ravinder Jha, Diwas Saun, Indrani Gupta

    Published 2024-04-01
    “…The COVID-19 pandemic exposed a lack of resilience in areas of drugs and vaccines but also in medical products. Objectives: The study analyzes India’s strengths and weaknesses in the trade of medical devices and identifies specific devices where India can attain self-sufficiency and areas where trade is still beneficial. …”
    Get full text
    Article
  2. 2302

    Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame. by Kamran Badizadegan, Kimberly M Thompson

    Published 2025-01-01
    “…Relatively recently, the GPLN expanded to include environmental surveillance to obtain additional information about poliovirus transmission in some geographies and to increase confidence about the absence of poliovirus transmission after successful eradication and/or the cessation of use of live-attenuated oral poliovirus vaccines (OPVs). Historical polio eradication strategic plans anticipated that successful global poliovirus eradication would lead to reduced requirements for financial investments for a poliovirus-specific surveillance system, and consequent transition of capacity and resources into integrated national disease surveillance systems. …”
    Get full text
    Article
  3. 2303

    Cognitive Behavioral Treatment of Blood-Injection-Injury Phobia: A Case Report by Elif Uzumcu, Sait Uluc

    Published 2018-12-01
    “…Blood-injection-injury phobia (BII) is a type of specific phobia that includes intensive anxiety and accompanying avoidance behaviors against medical procedures such as getting blood drawn, vaccination, having an injection and injuries. Unlike other specific phobias, physiological responses (e.g., fainting), called vasovagal syncope, are encountered in blood-injection-injury phobia. …”
    Get full text
    Article
  4. 2304

    HISTORY OF HIGHLY PATHOGENIC AVIAN INFLUENZA ERADICATION IN RUSSIAN FEDERATION IN 2016–2017 by M. S. Volkov, V. N. Irza, A. V. Varkentin

    Published 2018-05-01
    “…For now, drastic measures still remain the only tool for the disease control and the strategy of limited targeted AI vaccination in the backyards minimizes the virus introduction to the commercial farms located in the risk zones.…”
    Get full text
    Article
  5. 2305

    Cleaner Production Quality Regulation Strategy of Pharmaceutical with Collusive Behavior and Patient Feedback by Junmei Rong, Lilong Zhu

    Published 2020-01-01
    “…However, the various types of counterfeit pharmaceuticals and fake vaccines exposed in the recent years have revealed many problems, such as lacking government regulation, loose quality management of companies, illegal profit of medical service agencies, and failure of patient complaints. …”
    Get full text
    Article
  6. 2306

    Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia by Ruth Alex, Shabaz Mohiuddin Gulam, Kiran Kumar

    Published 2022-01-01
    “…There was only one death among 14 patients who received vaccination. There was no significant difference in mortality among patients with comorbidities such as diabetes, hypertension, dyslipidemia, obesity, and pulmonary diseases, hypothesizing that administration of TCZ improves the outcomes in COVID-19 patients with these comorbidities.…”
    Get full text
    Article
  7. 2307

    Attention-Based Hybrid Deep Learning Models for Classifying COVID-19 Genome Sequences by A. M. Mutawa

    Published 2025-01-01
    “…New viral strains may resist vaccines. Categorizing genetic sequences helps researchers track changes and assess immunization efficacy. …”
    Get full text
    Article
  8. 2308

    Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System by Farzaneh Ketabchi, Sina Jamzad

    Published 2022-01-01
    “…The condition is forcing physicians to adopt new treatment strategies while emphasizing continuation of vaccination programs. The renin-angiotensin system plays an important role in the development and progression of COVID-19 patients. …”
    Get full text
    Article
  9. 2309

    BharatSim: An agent-based modelling framework for India. by Philip Cherian, Jayanta Kshirsagar, Bhavesh Neekhra, Gaurav Deshkar, Harshal Hayatnagarkar, Kshitij Kapoor, Chandrakant Kaski, Ganesh Kathar, Swapnil Khandekar, Saurabh Mookherjee, Praveen Ninawe, Riz Fernando Noronha, Pranjal Ranka, Vaibhhav Sinha, Tina Vinod, Chhaya Yadav, Debayan Gupta, Gautam I Menon

    Published 2024-12-01
    “…, (ii) How do new variants alter disease dynamics in the background of prior infections and vaccinations? and (iii) How can the effects of varied non-pharmaceutical interventions (NPIs) be quantified for a model Indian city? …”
    Get full text
    Article
  10. 2310

    Breeding for disease resilience: opportunities to manage polymicrobial challenge and improve commercial performance in the pig industry by Xuechun Bai, Graham S. Plastow

    Published 2022-01-01
    “…Genome editing to produce pigs resistant to major diseases may complement selection for disease resilience along with continued efforts in the more traditional areas of biosecurity, vaccination and treatment. Altogether genomic approaches provide exciting opportunities for the pig industry to overcome the challenges provided by hard-to-manage diseases as well as new environmental challenges associated with climate change.…”
    Get full text
    Article
  11. 2311

    Risk factors of development of hepatocellular carcinoma by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya, I. A. Sokolina, Ye. N. German, M. V. Bundina

    Published 2009-02-01
    “…Prophylaxis of HCC should include prevention of hepatites B and C viruses infection, elimination of hepatotoxic substances, hepatitis B virus vaccination, antiviral therapy for patients with hepatites B and С. …”
    Get full text
    Article
  12. 2312

    A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period by Xiaona Li, Ruili Li, Qiguo Lian, Yang Wang, Wenkui Gu, Qinghe Meng

    Published 2023-01-01
    “…The low reproduction number and the Omicron outbreak being suppressed within a short time marked the effectiveness of the implemented public health measures, such as nucleic acid screening, social distancing, masking, vaccination, medical treatment of patients, and isolation of close contacts. …”
    Get full text
    Article
  13. 2313

    Innovative immunotherapies and emerging treatments in type 1 diabetes management by Malek Zarei, Mohammad Abbas Sheikholeslami, Masoud Mozaffari, Yassar Mortada

    Published 2025-01-01
    “…Antigen-dependent strategies focus on inducing immune tolerance to specific beta cell antigens, with mixed results from clinical trials involving autoantigen vaccines like GAD65. Beta cell therapies, including islet transplantation, offer promising outcomes but face challenges related to immunosuppression and donor availability. …”
    Get full text
    Article
  14. 2314

    AI Can Be a Powerful Social Innovation for Public Health if Community Engagement Is at the Core by Alessandra N Bazzano, Andrea Mantsios, Nicholas Mattei, Michael R Kosorok, Aron Culotta

    Published 2025-01-01
    “…Public health practitioners and researchers have historically innovated in areas like vaccination and sanitation but have been slower in adopting emerging technologies such as generative AI. …”
    Get full text
    Article
  15. 2315

    Concentration of viruses and electron microscopy by I. D. Petrova, B. N. Zaitsev, O. S. Taranov

    Published 2020-05-01
    “…Electron microscopy is also applied to ecological studies to detect viruses in the environment, to analysis of technological processes in the production of vaccines and other biotechnological components, and to diagnostics. …”
    Get full text
    Article
  16. 2316

    The cost of typhoid illness in low- and middle-income countries, a scoping review of the literature. by Frederic Debellut, Alena Friedrich, Ranju Baral, Clint Pecenka, Emmanuel Mugisha, Kathleen M Neuzil

    Published 2024-01-01
    “…New means of prevention became available with the prequalification of typhoid conjugate vaccines (TCV) by the World Health Organization (WHO) in 2018. …”
    Get full text
    Article
  17. 2317

    Bovine leukosis control measures by A. R. Yagudin, S. A. Schislenko, I. A. Usova, I. Y. Stroganova

    Published 2022-09-01
    “…The paper gives a brief description of the agricultural establishment: its zoosanitary status as well as zootechnical, veterinary, therapeutic and preventive measures (disinsection, deratization, vaccination). Based on the data obtained, we found the ultimate cause of bovine leukosis on the farm: presumably, these were crossbred animals brought into the farm. …”
    Get full text
    Article
  18. 2318

    The Conservative Physiology of the Immune System. A Non-Metaphoric Approach to Immunological Activity by Nelson M. Vaz, Gustavo C. Ramos, Vitor Pordeus, Claudia R. Carvalho

    Published 2006-01-01
    “…Historically, immunology emerged as a biomedical science, concerned with host defense and production of anti-infectious vaccines. In the late 50s, selective theories were proposed and from then on, immunology has been based in a close association with the neo-Darwinian principles, such as random generation of variants (lymphocyte clones), selection by extrinsic factors (antigens)—and, more generally, on genetic determinism and functionalism. …”
    Get full text
    Article
  19. 2319

    Optimization of Conditions for Production of Soluble <i>E. coli</i> Poly(A)-Polymerase for Biotechnological Applications by Igor P. Oscorbin, Maria S. Kunova, Maxim L. Filipenko

    Published 2025-01-01
    “…In vitro, PAP 1 is used to prepare libraries for RNAseq and to produce mRNA vaccines. However, <i>E. coli</i> PAP 1’s toxicity and instability in low-salt buffers complicate its expression and purification. …”
    Get full text
    Article
  20. 2320

    Pangenome Analysis of Helicobacter pylori Isolates from Selected Areas of Africa Indicated Diverse Antibiotic Resistance and Virulence Genes by Biigba Yakubu, Edwin Moses Appiah, Andrews Frimpong Adu

    Published 2024-01-01
    “…The challenge facing Helicobacter pylori (H. pylori) infection management in some parts of Africa is the evolution of drug-resistant species, the lack of gold standard in diagnostic methods, and the ineffectiveness of current vaccines against the bacteria. It is being established that even though clinical consequences linked to the bacteria vary geographically, there is rather a generic approach to treatment. …”
    Get full text
    Article